Seroprevalence of Leptospiral Antibodies in Stray Dogs in Mashhad, Iran
World Small Animal Veterinary Association World Congress Proceedings, 2003
A.R Kamrani; K. Sardari
School of Veterinary Medicine, Ferdowsi University
Mashhad, Iran

Objectives

This is the first serological study of leptospirosis in Mashhad, Iran, in order to determine the predominant serovars of leptospira in stray dogs population in this region of country.

Materials & Methods

Serum samples collected from 292 stray dogs during april 30 to the end of September 2002 from the Mashhad area were tested for leptospira antibodies, using the microscopic agglutination test.

Results

The overall leptospiral seroprevalence were 42 (14.38%) out of 292 sera sampled. 35 (11.98%) sera reacted with Canicola Hondutrech, 14 (4.79%) with Pomona, 7 (2.39%) with Sejroe Hardjo, 5 (1.71%) with Gripotyphosa and 2 (0.68%) with icterohaemorrhagiae.

Conclusion

In order to effective coverage of vaccination, identification of the predominant serovars in each region is essential. Because of close contact between stray and owned dogs in many areas especially in the suburbs, our achieved results can be almost representative of the predominant serovars in owned dogs population in Mashhad. At the present time the current vaccines used against dog leptospirosis in Mashhad, include canicola, icterohaemorrhagiae and grippotyphosa. Therefore we strongly recommend the polyvalent vaccines, including Pomona and hardjo in addition to the mentioned serovars.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

A. R. Kamrani
School of Veterinary Medicine, Ferdowsi University
Mashhad, Iran


MAIN : Infectious Disease : Leptospira: Iran
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27